Polymorphisms in folate-related genes: Impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese

Leukemia and Lymphoma

Volumn 52, Issue 9, 2011, Pages 1770-1776

  Yang, Lin ^a   Liu, Liang ^a   Wang, Jianxiang ^a   Qiu, Lugui ^a   Mi, Yingchang ^a   Ma, Xiaotang ^a   Xiao, Zhijian ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

genetic and other predisposing conditions; Lymphoid leukemia; molecular genetics

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; FOLIC ACID; MEMBRANE PROTEIN; PROTEIN DHFR 19; PROTEIN MTHFD1; PROTEIN MTHFR; PROTEIN MTR; PROTEIN MTRR; PROTEIN RFC1; PROTEIN SHMT1; PROTEIN TYMS; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK; YOUNG ADULT;

EID: 80052052583     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.578186     Document Type: Article

References (40)

1. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-524. (Pubitemid 28460290)
2. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-12815. (Pubitemid 29513584)
3. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-3791. (Pubitemid 34534552)
4. Skibola CF, Forrest MS, Coppedé F, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155-2162. (Pubitemid 39297871)
5. de Jonge R, Tissing WJ, Hooijberg JH, et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009;113:2284-2289.
6. Chango A, Emery-Fillon N, deCourcy GP, et al. A polymorphism (80G4A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310-315.
7. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003;55:3-29. (Pubitemid 36078452)
8. Robey RW, Polgar O, Deeken J, To KW, Bates SE. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 2007;26:39-57. (Pubitemid 46452182)
9. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 2004;124A:339-345. (Pubitemid 38141374)
10. Dulucq S, St-Onge G, Gagné V, et al. DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 2008;111:3692-3700.
11. Bagley PJ, Selhub J. A common mutation in the methylenete-trahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 1998;95:13217-13220. (Pubitemid 28509551)
12. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorour-acil and methotrexate. J Natl Cancer Inst 2004;96:134-144. (Pubitemid 38195904)
13. Etienne MC, Ilc K, Formento JL, et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br J Cancer 2004;90:526-534. (Pubitemid 38250655)
14. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995;20: 191-197.
15. Mauritz R, Beumer IJ, Marsh S, et al. Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients. Nucleosides Nucleotides Nucleic Acids 2004;23: 1381-1384. (Pubitemid 39625929)
16. Matsuo K, Suzuki R, Hamajima N, et al. Association between polymorphisms of folate-and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001;97:3205-3209.
17. Matsuo K, Hamajima N, Suzuki R, et al. Methylenetetrahy-drofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 2004;77: 351-357. (Pubitemid 39578315)
18. Wiemels JL, Smith RN, Taylor GM, et al. Methylenetetrahy-drofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001;98:4004-4009. (Pubitemid 32249888)
19. Franco RF, Simoes BP, Tone LG, Gabellini SM, Zago MA, Falcao RP. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001;115:616-618. (Pubitemid 34015653)
20. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257. (Pubitemid 38029946)
21. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate re-ductase polymorphisms and leukemia risk: a HuGE minire-view. Am J Epidemiol 2003;157:571-582. (Pubitemid 36368527)
22. Gemmati D, Ongaro A, Scapoli GL, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004;13:787-794. (Pubitemid 38737868)
23. Hishida A, Matsuo K, Hamajima N, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003;88:159-166. (Pubitemid 37101493)
24. de Jonge R, Hooijberg JH, van Zelst BD, et al. Effect of polymorphisms in folate-related genes on in vitro methotrex-ate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005;106:717-720. (Pubitemid 40981271)
25. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999;10:66-88.
26. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295.
27. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004;22:4632-4642. (Pubitemid 41185132)
28. Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G. Impact of folate deficiency on DNA stability. J Nutr 2002;132:2444S-2449S. (Pubitemid 34848124)
29. Lucock M. Is folic acid the ultimate functional food component for disease prevention?BMJ 2004;328:211-214. (Pubitemid 38147076)
30. Semsei AF, Erdélyi DJ, Ungvári I, et al. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk Res 2008;32:1214-1220.
31. Kondo C, Suzuki H, Itoda M, et al. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm Res 2004;21:1895-1903. (Pubitemid 39390103)
32. Kager L, Cheok M, Yang W, et al. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 2005;115:110-117. (Pubitemid 40385511)
33. Assaraf YG. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist Updat 2006;9:227-246. (Pubitemid 44750843)
34. Fotoohi AK, Assaraf YG, Moshfegh A, et al. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracel-lular levels of folate and nucleotide biosynthesis. Biochem Pharmacol 2009;77:1410-1417.
35. Yates Z, Lucock M. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci 2005;77:2735-2742. (Pubitemid 41297860)
36. Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1956-1963. (Pubitemid 44664274)
37. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009;41:1006-1010.
38. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methyle-netetrahydrofolate reductase. Nat Genet 1995;10:111-113.
39. Kluijtmans LA, Boers GH, Trijbels FJ, van Lith-Zanders HM, van den Heuvel LP, Blom HJ. A common 844INS68 insertion variant in the cystathionine beta-synthase gene. Biochem Mol Med 1997;62:23-25. (Pubitemid 27495276)
40. Lievers KJ, Boers GH, Verhoef P, et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001;79:522-528. (Pubitemid 32905549)